News articles

Eindhoven, the Netherlands, November 25, 2021 – The efficacy of an instrument-integrated OCT (iiOCT)-based distance sensor during robotic vitreoretinal surgery using the Preceyes Surgical System was assessed in this study. This iiOCT-based sensor was tested successfully and promises reliable use Read more…

Eindhoven, the Netherlands, November 14, 2021 – This study reports the results of a first-in-human study using a robotic device to assist subretinal drug delivery in patients undergoing vitreoretinal surgery for macular haemorrhage. After standard vitrectomy, intraoperative OCT-guided subretinal injection Read more…

Eindhoven, the Netherlands, December 30, 2020 – Preceyes has appointed Jim Mazzo as Chairman of its supervisory board. Jim Mazzo is a long time leader in the ophthalmic medical devices industry with over 40 years of proven experience and renowned Read more…

Eindhoven, the Netherlands, May 17, 2021 – Subretinal injection is a method for gene delivery to treat genetic diseases of the photoreceptors and retinal pigment epithelium. A reflux-free subretinal injection is important to allow effective, safe, and cost-effective gene therapy Read more…

Eindhoven, the Netherlands, January 21, 2021 –Preceyes B.V. (NL) and the Mount Sinai Health System (US) have entered into a long-term strategic collaboration with the anticipated aim of further developing robot-assisted ocular surgical procedures. As part of the collaboration, Mount Read more…

Eindhoven, October 15th 2020 – Preceyes BV, Sensoptic SA, Medicel AG and the University of Bern have started a H2020 Eurostars project for the advancement of a smart sensorized instrument for retinal surgery. The instrument measures the distance of the Read more…

New York, October 8th 2020 – During its Bicentennial Celebration Year, New York Eye and Ear Infirmary of Mount Sinai (NYEE), America’s first eye hospital founded in 1820, is once again breaking new ground by introducing a micro-surgical robotic system Read more…

Eindhoven, The Netherlands, June 5, 2020 – Preceyes B.V. has received the ISO-EN 13485:2016 certification for its quality management system, effectively obtaining approval for the continued commercialization and production of its CE-marked PRECEYES Surgical System R1.1 under the changing medical Read more…

Eindhoven, The Netherlands, December 13, 2019 – Researchers from the Copenhagen University Hospital Rigshospitalet have concluded that robot-assisted vitreoretinal surgery improves precision and limits tissue damage compared with that of manual surgery. This comes initially at the cost of time, Read more…

Eindhoven, The Netherlands, September 23, 2019 – Preceyes B.V., the medical robotics company developing and commercializing the first market-cleared robot for retina surgery, announced that it has appointed Dr. Kester Nahen as its Chief Commercial Officer. Dr. Nahen is a Read more…